Life Sciences Software Market Update – January 2022

January 13, 2022. MPG actively tracks the life sciences software landscape and has been instrumental in strategic deals across the drug development & commercialization spectrum. We’ve noticed a number of recent trends and developments:

• Life sciences and medical device manufacturers continue to rapidly digitize operations and compliance functions, leading to large scale adoption of quality management software systems

• Interest in commercialization services is reaching fever pitch as pharma/med device aggressively expand new therapies pipelines amidst rising demand through the pandemic

• Emphasis on robust patient/physician and trial data assets and insights-based decision making is driving M&A and investment activity across pre-market and post-market analytics vendors

• Aggressive financial sponsor interest in the life sciences software and services, with multiple tier-one software private equity firms recently placing bets on platforms